Bellerophon Therapeutics Inc (BLPH):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Bellerophon Therapeutics Inc (BLPH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8309
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary product candidate, INOpulse, a combination drug-device therapy intended for the treatment of pulmonary hypertension associated with interstitial lung disease, pulmonary hypertension associated with sarcoidosis and pulmonary hypertension associated with chronic obstructive pulmonary disease. It develops INOpulse platform is based on its proprietary pulsatile nitric oxide delivery device. Bellerophon Therapeutics is headquartered in Warren, New Jersey, the US.

Bellerophon Therapeutics Inc (BLPH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bellerophon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Bellerophon Therapeutics Raises Funds through Venture Financing 11
Bellerophon Therapeutics Raises Funds Through Venture Financing 12
Bellerophon Therapeutics Secures USD80 Million in Venture Funding 13
Equity Offering 14
Bellerophon Therapeutics Plans to Raise up to USD100 Million in Public offering of Securities 14
Bellerophon Therapeutics Plans to Raise Funds through Public Offering 15
Bellerophon Therapeutics Raises USD23.4 Million in Private Placement of Units 16
Bellerophon Therapeutics Raises USD3 Million in Private Placement of Shares and Warrants 18
Bellerophon Therapeutics Raises USD12 Million in Public Offering of Shares 19
Bellerophon Therapeutics Raises USD60 Million in IPO 20
Bellerophon Therapeutics Inc – Key Competitors 22
Bellerophon Therapeutics Inc – Key Employees 23
Bellerophon Therapeutics Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Financial Announcements 25
Aug 01, 2018: Bellerophon provides business update and reports second quarter 2018 financial results 25
May 10, 2018: Bellerophon Provides Business Update and Reports First Quarter 2018 Financial Results 27
Mar 15, 2018: Bellerophon Reports Fourth Quarter and Full-Year 2017 Financial Results 29
Nov 07, 2017: Bellerophon Provides Business Update and Reports Third Quarter 2017 Financial Results 31
Aug 07, 2017: Bellerophon Reports Second Quarter 2017 Financial Results and Provides Business Update 33
May 15, 2017: Bellerophon Reports First Quarter 2017 Financial Results and Provides Business Update 35
Mar 13, 2017: Bellerophon Reports Fourth Quarter 2016 Financial Results and Provides Business Update 37
Corporate Communications 39
Nov 30, 2017: Bellerophon Appoints Ted Wang, Ph.D., of Puissance Capital Management, to its Board of Directors 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bellerophon Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Bellerophon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bellerophon Therapeutics Raises Funds through Venture Financing 11
Bellerophon Therapeutics Raises Funds Through Venture Financing 12
Bellerophon Therapeutics Secures USD80 Million in Venture Funding 13
Bellerophon Therapeutics Plans to Raise up to USD100 Million in Public offering of Securities 14
Bellerophon Therapeutics Plans to Raise Funds through Public Offering 15
Bellerophon Therapeutics Raises USD23.4 Million in Private Placement of Units 16
Bellerophon Therapeutics Raises USD3 Million in Private Placement of Shares and Warrants 18
Bellerophon Therapeutics Raises USD12 Million in Public Offering of Shares 19
Bellerophon Therapeutics Raises USD60 Million in IPO 20
Bellerophon Therapeutics Inc, Key Competitors 22
Bellerophon Therapeutics Inc, Key Employees 23

List of Figures
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bellerophon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bellerophon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Bellerophon Therapeutics Inc (BLPH):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Welspun Corp Ltd:企業の戦略・SWOT・財務情報
    Welspun Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary Welspun Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Yangarra Resources Ltd (YGR):企業の財務・戦略的SWOT分析
    Summary Yangarra Resources Ltd (Yangarra) is an oil and gas company that explores, develops and produces oil and natural gas resources. It owns and operates oil and gas properties in Medicine Hat, Central Alberta, and Jaslan. It has infrastructure and land holdings. Central Alberta productive zones …
  • Neurimmune Holding AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Neurimmune Holding AG (Neurimmune), formerly Neurimmune Therapeutics AG is a biopharmaceutical company that develops immunotherapeutics for human diseases. The company’s pipeline products include human-derived monoclonal antibodies developed for the treatment and prevention of human neurodeg …
  • Sanofi (SAN)-製薬・医療分野:企業M&A・提携分析
    Summary Sanofi is a healthcare company, which focuses on the research, development, manufacture and marketing a wide range of medicines and vaccines. Its product portfolio includes medicines for the treatment of cancer, diabetes, rare diseases, multiple sclerosis and cardiovascular diseases; human v …
  • AB-Biotics SA (ABB):製薬・医療:M&Aディール及び事業提携情報
    Summary AB-Biotics SA (AB-Biotics) is a provider of probiotics, pipeline products, specialty dietary supplements, and other functional ingredients. The company’s products comprise iron-containing ingredients, lactobacillus plantarum, probiotic products, gastrointestinal treatment products, proprieta …
  • AF AB (AF B):電力:M&Aディール及び事業提携情報
    Summary AF AB is an engineering and consulting company. It offers various services such as product development and IT support to several sectors including automotive, telecom, defense and life sciences. The company also provides services such as communications systems management, development of cust …
  • U.S. National Geospatial-Intelligence Agency:企業の戦略的SWOT分析
    U.S. National Geospatial-Intelligence Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Voith GmbH & Co KGaA:企業の戦略的SWOT分析
    Voith GmbH & Co KGaA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Indeck Energy Services Inc:企業の戦略的SWOT分析
    Indeck Energy Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Indiana Municipal Power Agency:電力:M&Aディール及び事業提携情報
    Summary Indiana Municipal Power Agency (IMPA) is a not-for-profit wholesale power provider supplying power to cities and communities across Indiana and Ohio. The agency was formed by its member utilities which enable them to share power resources and provide electricity economically to their custome …
  • Cti Engineering Co Ltd
    Cti Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Cti Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Raya Holding (RAYA):企業の財務・戦略的SWOT分析
    Raya Holding (RAYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Ormat Technologies Inc (ORA):企業の財務・戦略的SWOT分析
    Ormat Technologies Inc (ORA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Saneca Pharmaceuticals as:製薬・医療:M&Aディール及び事業提携情報
    Summary Saneca Pharmaceuticals as (Saneca Pharma) is a contract development and manufacturing organization that develops and manufactures active pharmaceutical ingredients and finished dosage forms. The organization provides products such as API's; 2-aminotridecane adipate, atorvastatin calcium crys …
  • Dalton Pharma Services-製薬・医療分野:企業M&A・提携分析
    Summary Dalton Pharma Services (Dalton) is a contract manufacturing company that offers discovery, development and contract manufacturing services. The company’s product categories include building blocks, coelenterazines, drugs and metabolites, glitazones, gmp APIs, excipients and reagents, heteroc …
  • SSM Health Care:企業の戦略的SWOT分析
    SSM Health Care - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • G4S Plc (GFS):企業の財務・戦略的SWOT分析
    G4S Plc (GFS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Erste Group Bank AG:企業の戦略・SWOT・財務情報
    Erste Group Bank AG - Strategy, SWOT and Corporate Finance Report Summary Erste Group Bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Century Insurance Company Limited:企業の戦略・SWOT・財務情報
    Century Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Century Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • True Corporation Public Company Limited:戦略・SWOT・企業財務分析
    True Corporation Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary True Corporation Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆